Current Understanding of the Pathogenesis of Dengue Virus Infection
- PMID: 33231723
- PMCID: PMC7815537
- DOI: 10.1007/s00284-020-02284-w
Current Understanding of the Pathogenesis of Dengue Virus Infection
Abstract
The pathogenesis of dengue virus infection is attributed to complex interplay between virus, host genes and host immune response. Host factors such as antibody-dependent enhancement (ADE), memory cross-reactive T cells, anti-DENV NS1 antibodies, autoimmunity as well as genetic factors are major determinants of disease susceptibility. NS1 protein and anti-DENV NS1 antibodies were believed to be responsible for pathogenesis of severe dengue. The cytokine response of cross-reactive CD4+ T cells might be altered by the sequential infection with different DENV serotypes, leading to further elevation of pro-inflammatory cytokines contributing a detrimental immune response. Fcγ receptor-mediated antibody-dependent enhancement (ADE) results in release of cytokines from immune cells leading to vascular endothelial cell dysfunction and increased vascular permeability. Genomic variation of dengue virus and subgenomic flavivirus RNA (sfRNA) suppressing host immune response are viral determinants of disease severity. Dengue infection can lead to the generation of autoantibodies against DENV NS1antigen, DENV prM, and E proteins, which can cross-react with several self-antigens such as plasminogen, integrin, and platelet cells. Apart from viral factors, several host genetic factors and gene polymorphisms also have a role to play in pathogenesis of DENV infection. This review article highlights the various factors responsible for the pathogenesis of dengue and also highlights the recent advances in the field related to biomarkers which can be used in future for predicting severe disease outcome.
Conflict of interest statement
None to declare.
Figures
Similar articles
-
Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.Front Cell Infect Microbiol. 2017 May 9;7:157. doi: 10.3389/fcimb.2017.00157. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28536674 Free PMC article.
-
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33194810 Free PMC article. Review.
-
Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge.Antiviral Res. 2020 Nov;183:104923. doi: 10.1016/j.antiviral.2020.104923. Epub 2020 Sep 23. Antiviral Res. 2020. PMID: 32979401
-
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.PLoS Pathog. 2014 Oct 2;10(10):e1004386. doi: 10.1371/journal.ppat.1004386. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25275316 Free PMC article.
-
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.Front Immunol. 2018 Apr 23;9:597. doi: 10.3389/fimmu.2018.00597. eCollection 2018. Front Immunol. 2018. PMID: 29740424 Free PMC article. Review.
Cited by
-
(E)-Guggulsterone Inhibits Dengue Virus Replication by Upregulating Antiviral Interferon Responses through the Induction of Heme Oxygenase-1 Expression.Viruses. 2021 Apr 20;13(4):712. doi: 10.3390/v13040712. Viruses. 2021. PMID: 33924157 Free PMC article.
-
Arbovirus-vector protein interactomics identifies Loquacious as a co-factor for dengue virus replication in Aedes mosquitoes.PLoS Pathog. 2022 Sep 8;18(9):e1010329. doi: 10.1371/journal.ppat.1010329. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36074777 Free PMC article.
-
Immunologic Crosstalk and Host-Specific Immune Signature Associated with Dengue.ACS Omega. 2024 Aug 20;9(36):37418-37429. doi: 10.1021/acsomega.4c02506. eCollection 2024 Sep 10. ACS Omega. 2024. PMID: 39281909 Free PMC article. Review.
-
Association Between a History of Dengue Fever and the Risk of Systemic Autoimmune Rheumatic Diseases: A Nationwide, Population-Based Case-Control Study.Front Med (Lausanne). 2021 Nov 3;8:738291. doi: 10.3389/fmed.2021.738291. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34805205 Free PMC article.
-
DENV-2 NS1 promotes AMPK-LKB1 interaction to activate AMPK/ERK/mTOR signaling pathway to induce autophagy.Virol J. 2023 Oct 11;20(1):231. doi: 10.1186/s12985-023-02166-0. Virol J. 2023. PMID: 37821951 Free PMC article.
References
-
- Hussain T, Jamal M, Rehman T, Andleeb S. Dengue: pathogenesis, prevention and treatment – a mini review. Adv Life Sci. 2015;2(3):110–114.
-
- Hawley WA, Reiter P, Copeland RS, Pumpuni CB, Craig GB. Aedes albopictus in North America: probable introduction in used tires from northern Asia. Science. 1987;236(4805):1114–1116. - PubMed
-
- Holmes EC. Molecular epidemiology and evolution of emerging infectious diseases. Br Med Bull. 1998;54(3):533–543. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials